Medtronic’s ICM Proves Cost-Effective In Preventing Recurrent Stroke
Executive Summary
A new study shows implantable cardiac monitors are a cost-effective tool for preventing recurrent strokes following a stroke suspected to be caused by atrial fibrillation.
You may also be interested in...
Minute Insight: Trials Sponsored By Medtronic and Biosense Webster Show Benefits Of AFib Ablation
Results from two industry-supported clinical trials published in the last week offer more support for treating atrial fibrillation with catheter ablation rather than medication alone.
Cardio Catch-Up: More Conferences, More New Data From Abbott And Medtronic
Medtech Insight’s Cardiovascular Catch-Up highlights some of the recent news on cardiovascular tech innovations in the last two months. This edition focuses on news from conferences, held over the last two months, including the Heart Rhythm Society and the TVT Structural Heart Summit.
Cardiologs’ AI Trial Demonstrates Effectiveness Of Remote ECG Monitoring
Cardiologs has completed a clinical trial ECG analysis platform with implantable loop recorders. It can remotely identify features that have previously been a burden to physicians.